AnalystsAmi FadiaAmi Fadia's Stock Forecasts
AnalystsAmi Fadia
Analyst Ranking
Top 21%
#1003 out of 4875 analysts
Average Return
+1.01%
Win Rate
42%160 out of 385
Risk vs Reward
Poor
Good
Ami Fadia's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +176.50% | $21.49 | $59.42 | 2023-11-07 - 2024-11-06 | Buy |
Revolution Medicines IncRVMD | +156.77% | $18.36 | $47.13 | 2023-10-23 - 2024-10-22 | Buy |
Merus NvMRUS | +149.13% | $19.46 | $48.48 | 2023-03-01 - 2024-02-29 | Buy |
Merus NvMRUS | +143.86% | $18.33 | $44.70 | 2023-04-06 - 2024-04-05 | Buy |
Blueprint Medicines CorpBPMC | +134.58% | $40.52 | $95.05 | 2023-02-27 - 2024-02-26 | Buy |
Ami Fadia Analyst Color
Get additional color on Ami Fadia's coverage of popular stocks
Ami Fadia's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Revolution Medicines IncRVMD | 23 | Buy | $57.00 | +41.02% | Reiterates | 3 days ago |
Avadel Pharmaceuticals PLCAVDL | 35 | Buy | $19.00 | +102.34% | Reiterates | 3 days ago |
Day One Biopharmaceuticals IncDAWN | 20 | Buy | $27.00 | +318.60% | Maintains | 4 days ago |
Jazz Pharmaceuticals PLCJAZZ | 27 | Buy | $200.00 | +104.54% | Reiterates | 4 days ago |
Harmony Biosciences Holdings IncHRMY | 37 | Buy | $49.00 | +43.91% | Reiterates | 4 days ago |
Neurocrine Biosciences IncNBIX | 2 | Buy | $139.00 | +20.13% | Maintains | 5 days ago |
Praxis Precision Medicines IncPRAX | 11 | Buy | $80.00 | +108.60% | Reiterates | 6 days ago |
Bicycle Therapeutics PLCBCYC | 20 | Buy | $29.00 | +247.72% | Reiterates | 9 days ago |
Blueprint Medicines CorpBPMC | 30 | Buy | $130.00 | +33.79% | Maintains | 13 days ago |
Immuneering CorpIMRX | 15 | Buy | $12.00 | +952.63% | Reiterates | a month ago |
Neumora Therapeutics IncNMRA | 8 | Buy | $5.00 | +654.15% | Reiterates | a month ago |
Merus NvMRUS | 27 | Buy | $83.00 | +102.93% | Reiterates | a month ago |
Acadia Pharmaceuticals IncACAD | 8 | Buy | $28.00 | +60.55% | Reiterates | a month ago |
Axsome Therapeutics IncAXSM | 13 | Buy | $153.00 | +41.98% | Reiterates | a month ago |
Intra Cellular Therapies IncITCI | 26 | Hold | $100.00 | -24.17% | Downgrades | 4 months ago |
Cogent Biosciences IncCOGT | 21 | Hold | $15.00 | +211.85% | Downgrades | 5 months ago |
Biogen IncBIIB | 36 | Hold | $270.00 | +128.48% | Downgrades | 6 months ago |
Sage Therapeutics IncSAGE | 6 | Buy | $70.00 | N/A | Reiterates | 2 years ago |
Theseus Pharmaceuticals IncTHRX | 5 | Buy | $23.00 | N/A | Reiterates | 2 years ago |
Seagen IncSGEN | 6 | Buy | $185.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Amryt Pharma PLCAMYT | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Myovant Sciences LtdMYOV | 3 | Hold | $26.00 | N/A | Maintains | 4 years ago |
Amarin Corp PLCAMRN | 2 | Buy | $320.00 | N/A | Maintains | 4 years ago |
Pacira Biosciences IncPCRX | 3 | Hold | $75.00 | N/A | Downgrades | 4 years ago |
Obseva SaOBSVF | 1 | Buy | $5.00 | N/A | Maintains | 4 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Hold | $13.65 | N/A | Maintains | 5 years ago |
Iterum Therapeutics PLCITRM | 4 | Hold | $22.50 | N/A | Maintains | 5 years ago |
Perrigo Co PLCPRGO | 3 | Buy | $63.00 | N/A | Maintains | 5 years ago |
Rvl Pharmaceuticals PLCRVLPQ | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Upgrades | 7 years ago |
Endo International PLCENDPQ | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 7 years ago |
Heron Therapeutics IncHRTX | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 7 years ago |
Scpharmaceuticals IncSCPH | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 7 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Strong Sell | $13.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.